Appendix 4D and Interim Report
Stock | Cleanspace Holdings Ltd (CSX.ASX) |
---|---|
Release Time | 25 Feb 2025, 9:24 a.m. |
Price Sensitive | Yes |
CleanSpace reports H1 FY25 results
- Revenue up 26% to $9.2m
- Operating EBITDA loss reduced to $0.4m
- Cash position of $8.3m
CleanSpace Holdings Limited reported a 26% increase in revenue to $9.2m for the first half of FY25, driven by broad-based growth across all regions. The company's operating EBITDA loss was reduced to $0.4m, a significant $2.1m improvement compared to the prior corresponding period. This was mainly due to the sales growth, an increase in gross margin from 71% to 74%, and a 6% reduction in operating expenses. The company's cash position remained healthy at $8.3m. CleanSpace continues to invest in research and development, with the launch of the CS WORK respirator in 2024 contributing to over 2,200 unit sales in Europe and Australia. The company has further new product developments in the pipeline to drive future growth. CleanSpace welcomed the appointment of Gabrielle O'Carroll as CEO, effective January 1, 2025, with previous CEO Graham McLean transitioning to the role of Chair.
The company is confident that its global growth journey is just beginning, with its clear and proven go-to-market model enabling strong relationships with distribution partners and serving its key customers. The company's innovation and new product pipeline are expected to fuel further market penetration and growth in future years.